APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ivosidenib

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Ivosidenib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025176 pages

Choose your research edition.

Industry ResearchIvosidenib Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Ivosidenib Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Ivosidenib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ivosidenib Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Ivosidenib Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Ivosidenib market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Ivosidenib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ivosidenib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ivosidenib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Ivosidenib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ivosidenib include Servier Pharmaceuticals. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ivosidenib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ivosidenib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ivosidenib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ivosidenib market size, projected growth trends, production technologies, key applications, and end-use industries.

Ivosidenib Segment by Company

Servier Pharmaceuticals

Ivosidenib Segment by Type

60 Tablets

30 Tablets

Ivosidenib Segment by Application

Hospital

Pharmacy

Ivosidenib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ivosidenib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ivosidenib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ivosidenib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ivosidenib market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ivosidenib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Ivosidenib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Ivosidenib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Ivosidenib Industry Trends Table 2. Ivosidenib Industry Drivers Table 3. Ivosidenib Industry Opportunities and Challenges Table 4. Ivosidenib Industry Restraints Table 5. Global Ivosidenib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Ivosidenib Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Ivosidenib Sales by Manufacturers (units) & (2021-2026) Table 8. Global Ivosidenib Sales Market Share by Manufacturers Table 9. Global Ivosidenib Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Ivosidenib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Ivosidenib Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Ivosidenib Manufacturers, Product Type & Application Table 13. Global Ivosidenib Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Ivosidenib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 60 Tablets Table 17. Major Manufacturers of 30 Tablets Table 18. Global Ivosidenib Sales by Type 2021 VS 2025 VS 2032 (units) Table 19. Global Ivosidenib Sales by Type (2021-2026) & (units) Table 20. Global Ivosidenib Sales by Type (2027-2032) & (units) Table 21. Global Ivosidenib Sales Market Share by Type (2021-2026) Table 22. Global Ivosidenib Sales Market Share by Type (2027-2032) Table 23. Global Ivosidenib Revenue by Type 2021 VS 2025 VS 2032 (units) Table 24. Global Ivosidenib Revenue by Type (2021-2026) & (units) Table 25. Global Ivosidenib Revenue by Type (2027-2032) & (units) Table 26. Global Ivosidenib Revenue Market Share by Type (2021-2026) Table 27. Global Ivosidenib Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Pharmacy Table 30. Global Ivosidenib Sales by Application 2021 VS 2025 VS 2032 (units) Table 31. Global Ivosidenib Sales by Application (2021-2026) & (units) Table 32. Global Ivosidenib Sales by Application (2027-2032) & (units) Table 33. Global Ivosidenib Sales Market Share by Application (2021-2026) Table 34. Global Ivosidenib Sales Market Share by Application (2027-2032) Table 35. Global Ivosidenib Revenue by Application 2021 VS 2025 VS 2032 (units) Table 36. Global Ivosidenib Revenue by Application (2021-2026) & (units) Table 37. Global Ivosidenib Revenue by Application (2027-2032) & (units) Table 38. Global Ivosidenib Revenue Market Share by Application (2021-2026) Table 39. Global Ivosidenib Revenue Market Share by Application (2027-2032) Table 40. Global Ivosidenib Sales by Region: 2021 VS 2025 VS 2032 (units) Table 41. Global Ivosidenib Sales by Region (2021-2026) & (units) Table 42. Global Ivosidenib Sales Market Share by Region (2021-2026) Table 43. Global Ivosidenib Sales Forecasted by Region (2027-2032) & (units) Table 44. Global Ivosidenib Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Ivosidenib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 46. North America Ivosidenib Sales by Country (2021-2026) & (units) Table 47. North America Ivosidenib Sales by Country (2027-2032) & (units) Table 48. Europe Ivosidenib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 49. Europe Ivosidenib Sales by Country (2021-2026) & (units) Table 50. Europe Ivosidenib Sales by Country (2027-2032) & (units) Table 51. Asia Pacific Ivosidenib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 52. Asia Pacific Ivosidenib Sales by Country (2021-2026) & (units) Table 53. Asia Pacific Ivosidenib Sales by Country (2027-2032) & (units) Table 54. South America, Middle East and Africa Ivosidenib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 55. South America, Middle East and Africa Ivosidenib Sales by Country (2021-2026) & (units) Table 56. South America, Middle East and Africa Ivosidenib Sales by Country (2027-2032) & (units) Table 57. Global Ivosidenib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Ivosidenib Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Ivosidenib Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Ivosidenib Revenue Market Share by Region (2021-2026) Table 61. Global Ivosidenib Revenue Market Share by Region (2027-2032) Table 62. Servier Pharmaceuticals Company Information Table 63. Servier Pharmaceuticals Business Overview Table 64. Servier Pharmaceuticals Ivosidenib Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Servier Pharmaceuticals Ivosidenib Product Portfolio Table 66. Servier Pharmaceuticals Recent Development Table 67. Key Raw Materials Table 68. Raw Materials Key Suppliers Table 69. Ivosidenib Distributors List Table 70. Ivosidenib Customers List Table 71. Research Programs/Design for This Report Table 72. Authors List of This Report Table 73. Secondary Sources Table 74. Primary Sources List of Figures Figure 1. Ivosidenib Product Image Figure 2. Global Ivosidenib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ivosidenib Market Size (2021-2032) & (US$ Million) Figure 4. Global Ivosidenib Sales (2021-2032) & (units) Figure 5. Global Ivosidenib Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Ivosidenib Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 60 Tablets Image Figure 9. 30 Tablets Image Figure 10. Global Ivosidenib Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 11. Global Ivosidenib Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Ivosidenib Sales Market Share by Type (2021-2032) Figure 13. Global Ivosidenib Revenue by Type (2021 VS 2025 VS 2032) & (units) Figure 14. Global Ivosidenib Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Ivosidenib Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Pharmacy Image Figure 18. Global Ivosidenib Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 19. Global Ivosidenib Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Ivosidenib Sales Market Share by Application (2021-2032) Figure 21. Global Ivosidenib Revenue by Application (2021 VS 2025 VS 2032) & (units) Figure 22. Global Ivosidenib Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Ivosidenib Revenue Market Share by Application (2021-2032) Figure 24. North America Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 25. North America Ivosidenib Sales Market Share by Country (2021-2032) Figure 26. U.S. Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 27. Canada Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 28. Mexico Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 29. Europe Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 30. Europe Ivosidenib Sales Market Share by Country (2021-2032) Figure 31. Germany Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 32. France Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 33. U.K. Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 34. Italy Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 35. Netherlands Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 36. Asia Pacific Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 37. Asia Pacific Ivosidenib Sales Market Share by Country (2021-2032) Figure 38. China Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 39. Japan Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 40. South Korea Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 41. Southeast Asia Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 42. India Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 43. Australia Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 44. South America, Middle East and Africa Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 45. South America, Middle East and Africa Ivosidenib Sales Market Share by Country (2021-2032) Figure 46. Brazil Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 47. South Africa Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 48. Saudi Arabia Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 49. Turkey Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 50. Argentina Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 51. UAE Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 52. Egypt Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 53. Chile Ivosidenib Sales and Growth Rate (2021-2032) & (units) Figure 54. Global Ivosidenib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Ivosidenib Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Ivosidenib Revenue (2021-2032) & (US$ Million) Figure 57. North America Ivosidenib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Ivosidenib Revenue (2021-2032) & (US$ Million) Figure 59. Europe Ivosidenib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Ivosidenib Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Ivosidenib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Ivosidenib Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Ivosidenib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Ivosidenib Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Ivosidenib Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 60 Tablets
  • 30 Tablets
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Servier Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ivosidenib Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ivosidenib Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Ivosidenib Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Ivosidenib Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Ivosidenib Market Dynamics
  1. 2.1 Ivosidenib Industry Trends
  2. 2.2 Ivosidenib Industry Drivers
  3. 2.3 Ivosidenib Industry Opportunities and Challenges
  4. 2.4 Ivosidenib Industry Restraints
3 Ivosidenib Market by Manufacturers
  1. 3.1 Global Ivosidenib Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Ivosidenib Sales by Manufacturers (2021-2026)
  3. 3.3 Global Ivosidenib Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Ivosidenib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ivosidenib Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Ivosidenib Manufacturers, Product Type & Application
  7. 3.7 Global Ivosidenib Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ivosidenib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ivosidenib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ivosidenib Tier 1, Tier 2, and Tier 3
4 Ivosidenib Market by Type
  1. 4.1 Ivosidenib Type Introduction
  2. 4.1.1 60 Tablets
  3. 4.1.2 30 Tablets
  4. 4.2 Global Ivosidenib Sales by Type
  5. 4.2.1 Global Ivosidenib Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ivosidenib Sales by Type (2021-2032)
  7. 4.2.3 Global Ivosidenib Sales Market Share by Type (2021-2032)
  8. 4.3 Global Ivosidenib Revenue by Type
  9. 4.3.1 Global Ivosidenib Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ivosidenib Revenue by Type (2021-2032)
  11. 4.3.3 Global Ivosidenib Revenue Market Share by Type (2021-2032)
5 Ivosidenib Market by Application
  1. 5.1 Ivosidenib Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Ivosidenib Sales by Application
  5. 5.2.1 Global Ivosidenib Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Ivosidenib Sales by Application (2021-2032)
  7. 5.2.3 Global Ivosidenib Sales Market Share by Application (2021-2032)
  8. 5.3 Global Ivosidenib Revenue by Application
  9. 5.3.1 Global Ivosidenib Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Ivosidenib Revenue by Application (2021-2032)
  11. 5.3.3 Global Ivosidenib Revenue Market Share by Application (2021-2032)
6 Global Ivosidenib Sales by Region
  1. 6.1 Global Ivosidenib Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ivosidenib Sales by Region (2021-2032)
  3. 6.2.1 Global Ivosidenib Sales by Region (2021-2026)
  4. 6.2.2 Global Ivosidenib Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ivosidenib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Ivosidenib Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Ivosidenib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Ivosidenib Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Ivosidenib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Ivosidenib Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Ivosidenib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Ivosidenib Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Ivosidenib Revenue by Region
  1. 7.1 Global Ivosidenib Revenue by Region
  2. 7.1.1 Global Ivosidenib Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Ivosidenib Revenue by Region (2021-2026)
  4. 7.1.3 Global Ivosidenib Revenue by Region (2027-2032)
  5. 7.1.4 Global Ivosidenib Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Ivosidenib Revenue (2021-2032)
  8. 7.2.2 North America Ivosidenib Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Ivosidenib Revenue (2021-2032)
  11. 7.3.2 Europe Ivosidenib Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Ivosidenib Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Ivosidenib Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Ivosidenib Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Ivosidenib Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Servier Pharmaceuticals
  2. 8.1.1 Servier Pharmaceuticals Company Information
  3. 8.1.2 Servier Pharmaceuticals Business Overview
  4. 8.1.3 Servier Pharmaceuticals Ivosidenib Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Servier Pharmaceuticals Ivosidenib Product Portfolio
  6. 8.1.5 Servier Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ivosidenib Value Chain Analysis
  2. 9.1.1 Ivosidenib Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ivosidenib Production Mode & Process
  6. 9.2 Ivosidenib Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ivosidenib Distributors
  9. 9.2.3 Ivosidenib Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst